rβ2-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity

Abstract

In dopaminergic (DA) substantia nigra (SN) neurons Cav2.3 R-type Ca2+-currents contribute to somatodendritic Ca2+-oscillations. This activity may contribute to the selective degeneration of these neurons in Parkinson's disease (PD) since Cav2.3-knockout is neuroprotective in a PD mouse model. Here we show that in tsA-201-cells the membrane-anchored β2-splice variants β2a and β2e are required to stabilize Cav2.3 gating properties allowing sustained Cav2.3 availability during simulated pacemaking and enhanced Ca2+-currents during bursts. We confirmed the expression of β2a- and β2e-subunit transcripts in the mouse SN and in identified SN DA neurons. Patch-clamp recordings of mouse DA midbrain neurons in culture and SN DA neurons in brain slices revealed SNX-482-sensitive R-type Ca2+-currents with voltage-dependent gating properties that suggest modulation by β2a- and/or β2e-subunits. Thus, β-subunit alternative splicing may prevent a fraction of Cav2.3 channels from inactivation in continuously active, highly vulnerable SN DA neurons, thereby also supporting Ca2+ signals contributing to the (patho)physiological role of Cav2.3 channels in PD.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Raw data have been provided for mean population data shown in Figures and Tables.

The following previously published data sets were used

Article and author information

Author details

  1. Anita Siller

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  2. Nadja T Hofer

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Giulia Tomagra

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Nicole Wiederspohn

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Simon Hess

    Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Julia Benkert

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Aisylu Gaifullina

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Desiree Spaich

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Johanna Duda

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Christina Poetschke

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Kristina Vilusic

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  12. Eva Maria Fritz

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    Competing interests
    The authors declare that no competing interests exist.
  13. Toni Schneider

    Institute of Neurophysiology, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Peter Kloppenburg

    Institute for Zoology, Biocenter, University of Cologne, Cologne, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4554-404X
  15. Birgit Liss

    Institute of Applied Physiology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  16. Valentina Carabelli

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
  17. Emilio Carbone

    Department of Drug Science, University of Torino, Torino, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2239-6280
  18. Nadine Jasmin Ortner

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    For correspondence
    nadine.ortner@uibk.ac.at
    Competing interests
    The authors declare that no competing interests exist.
  19. Jörg Striessnig

    Department of Pharmacology and Toxicology, University of Innsbruck, Innsbruck, Austria
    For correspondence
    joerg.striessnig@uibk.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9406-7120

Funding

Austrian Science Fund (P27809,P35722,CavX-DOC 30 doc.fund)

  • Jörg Striessnig

Tyrolean Science Fund (UNI-0404/2345)

  • Nadine Jasmin Ortner

Italian Miur (2015FNWP34)

  • Emilio Carbone

Compagnia di San Paolo (CSTO165284)

  • Emilio Carbone

Austrian Science Fund (P35087)

  • Nadine Jasmin Ortner

Hamburg Institute for Advanced Study (Research Fellowship)

  • Birgit Liss

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal experiments and procedures were performed in strict accordance with the European Community's Council Directive 2010/63/UE and approved by the Italian Ministry of Health and the Local Organism responsible for animal welfare at the University of Torino (authorization DGSAF 0011710-P-26/07/2017) and the local authorities at the University of Ulm (Regierungspräsidium Tübingen, Ref: 35/9185.81-3; Reg. Nr. o.147) and University of Cologne (LANUV NRW, Recklinghausen, Germany (84-02.05.20.12.254).

Copyright

© 2022, Siller et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,278
    views
  • 344
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anita Siller
  2. Nadja T Hofer
  3. Giulia Tomagra
  4. Nicole Wiederspohn
  5. Simon Hess
  6. Julia Benkert
  7. Aisylu Gaifullina
  8. Desiree Spaich
  9. Johanna Duda
  10. Christina Poetschke
  11. Kristina Vilusic
  12. Eva Maria Fritz
  13. Toni Schneider
  14. Peter Kloppenburg
  15. Birgit Liss
  16. Valentina Carabelli
  17. Emilio Carbone
  18. Nadine Jasmin Ortner
  19. Jörg Striessnig
(2022)
rβ2-subunit alternative splicing stabilizes Cav2.3 Ca2+ channel activity during continuous midbrain dopamine neuron-like activity
eLife 11:e67464.
https://doi.org/10.7554/eLife.67464

Share this article

https://doi.org/10.7554/eLife.67464

Further reading

    1. Neuroscience
    Alessandro Piccin, Anne-Emilie Allain ... Angelo Contarino
    Research Article

    Substance-induced social behavior deficits dramatically worsen the clinical outcome of substance use disorders; yet, the underlying mechanisms remain poorly understood. Herein, we investigated the role for the corticotropin-releasing factor receptor 1 (CRF1) in the acute sociability deficits induced by morphine and the related activity of oxytocin (OXY)- and arginine-vasopressin (AVP)-expressing neurons of the paraventricular nucleus of the hypothalamus (PVN). For this purpose, we used both the CRF1 receptor-preferring antagonist compound antalarmin and the genetic mouse model of CRF1 receptor-deficiency. Antalarmin completely abolished sociability deficits induced by morphine in male, but not in female, C57BL/6J mice. Accordingly, genetic CRF1 receptor-deficiency eliminated morphine-induced sociability deficits in male mice. Ex vivo electrophysiology studies showed that antalarmin also eliminated morphine-induced firing of PVN neurons in male, but not in female, C57BL/6J mice. Likewise, genetic CRF1 receptor-deficiency reduced morphine-induced firing of PVN neurons in a CRF1 gene expression-dependent manner. The electrophysiology results consistently mirrored the behavioral results, indicating a link between morphine-induced PVN activity and sociability deficits. Interestingly, in male mice antalarmin abolished morphine-induced firing in neurons co-expressing OXY and AVP, but not in neurons expressing only AVP. In contrast, in female mice antalarmin did not affect morphine-induced firing of neurons co-expressing OXY and AVP or only OXY, indicating a selective sex-specific role for the CRF1 receptor in opiate-induced PVN OXY activity. The present findings demonstrate a major, sex-linked, role for the CRF1 receptor in sociability deficits and related brain alterations induced by morphine, suggesting new therapeutic strategy for opiate use disorders.

    1. Neuroscience
    Mathias Guayasamin, Lewis R Depaauw-Holt ... Ciaran Murphy-Royal
    Research Article

    Early-life stress can have lifelong consequences, enhancing stress susceptibility and resulting in behavioural and cognitive deficits. While the effects of early-life stress on neuronal function have been well-described, we still know very little about the contribution of non-neuronal brain cells. Investigating the complex interactions between distinct brain cell types is critical to fully understand how cellular changes manifest as behavioural deficits following early-life stress. Here, using male and female mice we report that early-life stress induces anxiety-like behaviour and fear generalisation in an amygdala-dependent learning and memory task. These behavioural changes were associated with impaired synaptic plasticity, increased neural excitability, and astrocyte hypofunction. Genetic perturbation of amygdala astrocyte function by either reducing astrocyte calcium activity or reducing astrocyte network function was sufficient to replicate cellular, synaptic, and fear memory generalisation associated with early-life stress. Our data reveal a role of astrocytes in tuning emotionally salient memory and provide mechanistic links between early-life stress, astrocyte hypofunction, and behavioural deficits.